title: Drug interchanges at the pharmacy: safe for cardiovascular disease?
abstract: With the development of sustained-release formulations for various chronic diseases, long-standing questions about the "interchangeability" of drugs have acquired new pertinence. A case in point is provided by verapamil.
authors.affiliation: Tufts University School of Medicine, Boston, Mass.
authors.forename: J D
authors.initials: JD
authors.lastname: McCue
mesh_terms: D000375:Aging / Q000378:metabolism; D001682:Biological Availability; D003692:Delayed-Action Preparations; D005769:Gastrointestinal Motility; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008508:Medication Errors; D013810:Therapeutic Equivalency; D014700:Verapamil / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D003692:Delayed-Action Preparations; D014700:Verapamil